Global Innovation Policy Center
GIPC is leading efforts to promote innovation and creativity globally by advocating for strong IP standards.
The U.S. Chamber of Commerce’s Global Innovation Policy Center is working around the world to champion innovation and creativity through intellectual property standards that create jobs, save lives, advance global economic and cultural prosperity, and generate breakthrough solutions to global challenges.
Explore more
Leadership
Latest Content
WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine:
3rd Annual IP Dialogue virtually convenes academic, industry, and public sector IP experts
The U.S. Chamber will challenge this flawed and harmful policy
WASHINGTON, D.C. - Ahead of the holiday shopping season, the U.S. Chamber of Commerce's Global Innovation Policy Center’s (GIPC) Shop Smart campaign is raising consumer awareness about counterfeit goods, the dangers of fake products, and the prevalence of online fraud and scams.
With more Americans shopping online this holiday season, it is more important than ever to stay diligent when it comes to counterfeits.
"Diversity drives innovation, not the other way around," said U.S. Chamber President Suzanne Clark at the Global Innovation Policy Center's Equality of Opportunity in the Innovation Economy event on October 1.
Gilead moves forward with remdesivir in trials to treat COVID-19.
On April 26, the Boeing Dreamlifter, a converted Boeing 747-400 Large Cargo Freighter, flew from Hong Kong to Greenville, South Carolina, with 1.5 million medical-grade masks destined for health care professionals at Prisma Health, the largest health care system in South Carolina.
WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and CEO of the Global Innovation Policy Center, David Hirschmann, issued the following statement today on Shira Perlmutter’s appointment as the 14th Register of Copyrights.
This submission complements the Chamber’s ongoing support for the Commission’s work to remove trade barriers and to protect intellectual property (IP) in the European Union (EU) and internationally . The Chamber respectfully offers several suggestions for how Europe can begin to reclaim a leadership role and become a more attractive investment destination for biopharmaceuticals and ensure Europeans can access the very latest innovative medicines.